FFAS03 list of results PDB0312 / PfamA26U

Shows best template from each database, and all templates with significant scores covering different query fragments

Results: 1-20 of 36422 next page >

# Query Length Result vs. Range Score %id Covered by template(s)
1 4E14 Entity 1(prereleased) 303 PfamA26U 6-300 -26.100 9 PF05448.7; Q9K5F2_BACPU/1-315; Acetyl xylan esterase (AXE1)
65-299 -37.700 10 PF12740.2; C0PR35_PICSI/37-294; Chlorophyllase enzyme
85-283 -52.100 15 PF07859.8; O66374_ACEPA/83-292; alpha/beta hydrolase fold
2 2LAA Entity 1(prereleased) 104 PfamA26U 4-81 -30.100 17 PF03423.8; Q8W1P1_ORYSA/508-599; Carbohydrate binding domain (family 25)
3 2LAB Entity 1(prereleased) 104 PfamA26U 4-81 -29.600 16 PF03423.8; Q8W1P1_ORYSA/508-599; Carbohydrate binding domain (family 25)
4 3PJH Entity 1(prereleased) 114 PfamA26U 10-93 -19.300 12 PF02758.11; IFI4_MOUSE/6-84; PAAD/DAPIN/Pyrin domain
5 2L6F Entity 1(prereleased) 215 PfamA26U 2-133 -53.400 50 PF03623.8; Q4RY69_TETNG/821-958; Focal adhesion targeting region
6 2L6H Entity 1(prereleased) 180 PfamA26U 2-132 -69.500 51 PF03623.8; Q4RY69_TETNG/821-958; Focal adhesion targeting region
7 2L6W Entity 1(prereleased) 39 PfamA26U 15-39 -8.210 28 PF07435.6; Q8YA70_LISMO/5-440; YycH protein
8 2L6V Entity 1(prereleased) 109 PfamA26U 18-98 -12.100 14 PF14277.1; C0F0R6_9FIRM/9-173; Domain of unknown function (DUF4364 topsan)
9 3Q4E Entity 2(prereleased) 69 PfamA26U 43-66 -7.290 25 PF09394.5; Q4DY71_TRYCR/14-109; Chagasin family peptidase inhibitor I42
10 3Q4E Entity 1(prereleased) 546 PfamA26U 11-366 -16.900 8 PF06873.6; Q22YK2_TETTH/1-399; Cell surface immobilisation antigen SerH
76-517 -38.200 11 PF02335.10; NRFA_BACFN/56-493; Cytochrome c552
141-411 -63.900 78 PF13447.1; Q2YA36_NITMU/164-434; Seven times multi-haem cytochrome CxxCH
11 3Q6O Entity 1(prereleased) 131 PfamA26U 13-124 -52.800 18 PF00085.15; PDIA4_MOUSE/56-159; Thioredoxin
12 3Q8J Entity 1(prereleased) 37 PfamA26U 8-36 -4.940 17 PF12894.2; B6GWF8_PENCW/7-55; Anaphase-promoting complex subunit 4 WD40 domain
13 3QDD Entity 1(prereleased) 237 PfamA26U 46-159 -20.500 19 PF13589.1; A5G4D8_GEOUR/22-165; Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase
14 3QD9 Entity 1(prereleased) 470 PfamA26U 2-416 -38.200 8 PF01216.12; CASQ1_HUMAN/5-390; Calsequestrin
24-133 -45.600 17 PF00085.15; PDIA4_MOUSE/56-159; Thioredoxin
15 3Q9R Entity 1(prereleased) 612 PfamA26U 8-91 -44.900 100 PF02922.13; GLGB_ECOLI/124-207; Carbohydrate-binding module 48 (Isoamylase N-terminal domain)
78-603 -12.100 11 PF13199.1; C9L2G8_9BACE/41-584; Glycosyl hydrolase family 66
157-460 -13.500 17 PF00128.19; MALT_AEDAE/44-406; Alpha amylase, catalytic domain
512-610 -43.200 24 PF02806.13; GLGB_CHLPN/621-718; Alpha amylase, C-terminal all-beta domain
16 3QB7 Entity 1(prereleased) 132 PfamA26U 4-128 -60.400 58 PF00727.13; A7LBR6_BISBO/25-133; Interleukin 4
17 3QB7 Entity 2(prereleased) 203 PfamA26U 2-90 -26.600 15 PF09067.5; Q6UAP7_TETNG/33-133; Erythropoietin receptor, ligand binding
91-189 -29.000 18 PF01108.12; I10R2_MOUSE/5-100; Tissue factor
18 2LIF Entity 1(prereleased) 27 PfamA26U 3-22 -15.100 75 PF01542.13; POLG_HCVTW/116-190; Hepatitis C virus core protein
19 3QL8 Entity 1(prereleased) 306 PfamA26U 12-294 -50.100 29 PF00069.20; KS6A1_MOUSE/407-664; Protein kinase domain
20 3QKN Entity 1(prereleased) 321 PfamA26U 40-276 -103.000 36 PF00102.22; O82656_ARATH/87-325; Protein-tyrosine phosphatase

FFAS is supported by the NIH grant R01-GM087218-01

jobs submitted since Jan 1, 2011

Comments and questions to: webmaster

#	Query	Length	Result vs.	Range	Score	%id	Covered by template(s)
1	`4E14 Entity 1(prereleased)`	`303`	`PfamA26U`	`6-300`	`-26.100`	`9`	`PF05448.7; Q9K5F2_BACPU/1-315; Acetyl xylan esterase (AXE1)`
				`65-299`	`-37.700`	`10`	`PF12740.2; C0PR35_PICSI/37-294; Chlorophyllase enzyme`
				`85-283`	`-52.100`	`15`	`PF07859.8; O66374_ACEPA/83-292; alpha/beta hydrolase fold`
2	`2LAA Entity 1(prereleased)`	`104`	`PfamA26U`	`4-81`	`-30.100`	`17`	`PF03423.8; Q8W1P1_ORYSA/508-599; Carbohydrate binding domain (family 25)`
3	`2LAB Entity 1(prereleased)`	`104`	`PfamA26U`	`4-81`	`-29.600`	`16`	`PF03423.8; Q8W1P1_ORYSA/508-599; Carbohydrate binding domain (family 25)`
4	`3PJH Entity 1(prereleased)`	`114`	`PfamA26U`	`10-93`	`-19.300`	`12`	`PF02758.11; IFI4_MOUSE/6-84; PAAD/DAPIN/Pyrin domain`
5	`2L6F Entity 1(prereleased)`	`215`	`PfamA26U`	`2-133`	`-53.400`	`50`	`PF03623.8; Q4RY69_TETNG/821-958; Focal adhesion targeting region`
6	`2L6H Entity 1(prereleased)`	`180`	`PfamA26U`	`2-132`	`-69.500`	`51`	`PF03623.8; Q4RY69_TETNG/821-958; Focal adhesion targeting region`
7	`2L6W Entity 1(prereleased)`	`39`	`PfamA26U`	`15-39`	`-8.210`	`28`	`PF07435.6; Q8YA70_LISMO/5-440; YycH protein`
8	`2L6V Entity 1(prereleased)`	`109`	`PfamA26U`	`18-98`	`-12.100`	`14`	`PF14277.1; C0F0R6_9FIRM/9-173; Domain of unknown function (DUF4364 topsan)`
9	`3Q4E Entity 2(prereleased)`	`69`	`PfamA26U`	`43-66`	`-7.290`	`25`	`PF09394.5; Q4DY71_TRYCR/14-109; Chagasin family peptidase inhibitor I42`
10	`3Q4E Entity 1(prereleased)`	`546`	`PfamA26U`	`11-366`	`-16.900`	`8`	`PF06873.6; Q22YK2_TETTH/1-399; Cell surface immobilisation antigen SerH`
				`76-517`	`-38.200`	`11`	`PF02335.10; NRFA_BACFN/56-493; Cytochrome c552`
				`141-411`	`-63.900`	`78`	`PF13447.1; Q2YA36_NITMU/164-434; Seven times multi-haem cytochrome CxxCH`
11	`3Q6O Entity 1(prereleased)`	`131`	`PfamA26U`	`13-124`	`-52.800`	`18`	`PF00085.15; PDIA4_MOUSE/56-159; Thioredoxin`
12	`3Q8J Entity 1(prereleased)`	`37`	`PfamA26U`	`8-36`	`-4.940`	`17`	`PF12894.2; B6GWF8_PENCW/7-55; Anaphase-promoting complex subunit 4 WD40 domain`
13	`3QDD Entity 1(prereleased)`	`237`	`PfamA26U`	`46-159`	`-20.500`	`19`	`PF13589.1; A5G4D8_GEOUR/22-165; Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase`
14	`3QD9 Entity 1(prereleased)`	`470`	`PfamA26U`	`2-416`	`-38.200`	`8`	`PF01216.12; CASQ1_HUMAN/5-390; Calsequestrin`
				`24-133`	`-45.600`	`17`	`PF00085.15; PDIA4_MOUSE/56-159; Thioredoxin`
15	`3Q9R Entity 1(prereleased)`	`612`	`PfamA26U`	`8-91`	`-44.900`	`100`	`PF02922.13; GLGB_ECOLI/124-207; Carbohydrate-binding module 48 (Isoamylase N-terminal domain)`
				`78-603`	`-12.100`	`11`	`PF13199.1; C9L2G8_9BACE/41-584; Glycosyl hydrolase family 66`
				`157-460`	`-13.500`	`17`	`PF00128.19; MALT_AEDAE/44-406; Alpha amylase, catalytic domain`
				`512-610`	`-43.200`	`24`	`PF02806.13; GLGB_CHLPN/621-718; Alpha amylase, C-terminal all-beta domain`
16	`3QB7 Entity 1(prereleased)`	`132`	`PfamA26U`	`4-128`	`-60.400`	`58`	`PF00727.13; A7LBR6_BISBO/25-133; Interleukin 4`
17	`3QB7 Entity 2(prereleased)`	`203`	`PfamA26U`	`2-90`	`-26.600`	`15`	`PF09067.5; Q6UAP7_TETNG/33-133; Erythropoietin receptor, ligand binding`
				`91-189`	`-29.000`	`18`	`PF01108.12; I10R2_MOUSE/5-100; Tissue factor`
18	`2LIF Entity 1(prereleased)`	`27`	`PfamA26U`	`3-22`	`-15.100`	`75`	`PF01542.13; POLG_HCVTW/116-190; Hepatitis C virus core protein`
19	`3QL8 Entity 1(prereleased)`	`306`	`PfamA26U`	`12-294`	`-50.100`	`29`	`PF00069.20; KS6A1_MOUSE/407-664; Protein kinase domain`
20	`3QKN Entity 1(prereleased)`	`321`	`PfamA26U`	`40-276`	`-103.000`	`36`	`PF00102.22; O82656_ARATH/87-325; Protein-tyrosine phosphatase`